Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Accounts Payables (2020 - 2026)

BioScience Health Innovations has reported Accounts Payables over the past 7 years, most recently at $6787.0 for Q1 2026.

  • Quarterly Accounts Payables fell 58.65% to $6787.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6787.0 through Mar 2026, down 58.65% year-over-year, with the annual reading at $6274.0 for FY2025, 23.73% down from the prior year.
  • Accounts Payables was $6787.0 for Q1 2026 at BioScience Health Innovations, up from $6274.0 in the prior quarter.
  • Over five years, Accounts Payables peaked at $16636.0 in Q2 2025 and troughed at $901.0 in Q2 2023.
  • The 5-year median for Accounts Payables is $7011.0 (2024), against an average of $7755.1.
  • Year-over-year, Accounts Payables surged 736.18% in 2022 and then plummeted 72.22% in 2024.
  • A 5-year view of Accounts Payables shows it stood at $2867.0 in 2022, then soared by 167.7% to $7675.0 in 2023, then grew by 7.18% to $8226.0 in 2024, then dropped by 23.73% to $6274.0 in 2025, then rose by 8.18% to $6787.0 in 2026.
  • Per Business Quant, the three most recent readings for BHIC's Accounts Payables are $6787.0 (Q1 2026), $6274.0 (Q4 2025), and $10165.0 (Q3 2025).